Balance Sheet - Sana Biotechnology, Inc. (SANA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 138.38 | 152.50 | 205.20 | 423.96 | 551.00 | 378.26 | 138.98 | 30.63 |
| Other current assets | 10.29 | 8.31 | 8.32 | 20.47 | 7.11 | 6.20 | 5.28 | 1.97 |
| Total current assets | 148.68 | 160.81 | 213.52 | 444.44 | 558.10 | 384.47 | 144.26 | 32.60 |
| Total non-current assets | 268.21 | 340.21 | 351.78 | 378.28 | 571.31 | 345.83 | 270.93 | 1.74 |
| Total assets | 416.89 | 501.02 | 565.30 | 822.72 | 1,129.41 | 730.30 | 415.19 | 34.33 |
| Total current liabilities | 78.73 | 45.43 | 64.49 | 111.50 | 99.24 | 31.45 | 19.32 | 1.79 |
| Total non-current liabilities | 177.28 | 205.08 | 213.31 | 211.90 | 301.67 | 1,120.03 | 538.41 | 45.74 |
| Total liabilities | 256.01 | 250.52 | 277.79 | 323.41 | 400.91 | 1,151.48 | 557.73 | 47.52 |
| Total stockholders' equity | 160.88 | 250.50 | 287.51 | 499.32 | 728.50 | -421.18 | -142.54 | -13.19 |
| Common shares outstanding | 253 | 231 | 195 | 188 | 166 | 188 | 187 | 187 |
Show Quarterly Balance Sheet
Balance Sheet - Sana Biotechnology, Inc. (SANA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 101.14 | 138.38 | 153.05 | 72.67 | 104.70 | 152.50 | 199.01 | 251.64 | 311.08 | 205.20 | 268.57 | 325.92 | 349.31 | 423.96 | 485.75 | 484.80 | 512.38 | 551.00 | 603.71 | 852.84 | 960.24 | 378.26 | 450.86 | 0.00 | 138.98 | 138.98 |
| Other current assets | 10.55 | 10.29 | 8.71 | 9.83 | 8.03 | 8.31 | 11.14 | 11.81 | 10.18 | 8.32 | 10.95 | 12.71 | 20.60 | 20.47 | 14.50 | 9.61 | 10.84 | 7.11 | 9.13 | 7.50 | 7.24 | 6.20 | 4.71 | 5.28 | ||
| Total current assets | 111.69 | 148.68 | 161.76 | 82.50 | 112.73 | 160.81 | 210.15 | 263.45 | 321.26 | 213.52 | 279.52 | 338.62 | 369.91 | 444.44 | 500.25 | 494.41 | 523.22 | 558.10 | 612.85 | 860.34 | 967.47 | 384.47 | 455.57 | 138.98 | 144.26 | |
| Total non-current assets | 261.90 | 268.21 | 273.67 | 279.14 | 332.74 | 340.21 | 349.24 | 355.21 | 360.11 | 351.78 | 351.92 | 368.53 | 377.02 | 378.28 | 397.85 | 476.68 | 524.39 | 571.31 | 619.91 | 399.50 | 336.99 | 345.83 | 312.15 | -138.98 | 270.93 | |
| Total assets | 373.59 | 416.89 | 435.43 | 361.65 | 445.47 | 501.02 | 559.39 | 618.67 | 681.38 | 565.30 | 631.44 | 707.15 | 746.93 | 822.72 | 898.10 | 971.09 | 1,047.61 | 1,129.41 | 1,232.75 | 1,259.84 | 1,304.47 | 730.30 | 767.72 | 415.19 | ||
| Total current liabilities | 86.27 | 78.73 | 35.51 | 33.44 | 33.16 | 45.43 | 47.00 | 50.69 | 52.90 | 64.49 | 66.64 | 112.11 | 102.78 | 111.50 | 114.81 | 97.11 | 93.51 | 99.24 | 92.01 | 42.83 | 35.15 | 31.45 | 26.54 | 19.32 | ||
| Total non-current liabilities | 168.09 | 177.28 | 204.61 | 205.65 | 203.24 | 205.08 | 219.91 | 228.33 | 253.33 | 213.31 | 198.94 | 240.01 | 215.89 | 211.90 | 217.27 | 234.48 | 252.45 | 301.67 | 310.66 | 311.11 | 387.33 | 1,120.03 | 1,052.35 | 538.41 | ||
| Total liabilities | 254.35 | 256.01 | 240.12 | 239.09 | 236.39 | 250.52 | 266.91 | 279.02 | 306.24 | 277.79 | 265.59 | 352.12 | 318.67 | 323.41 | 332.08 | 331.58 | 345.96 | 400.91 | 402.67 | 353.94 | 422.48 | 1,151.48 | 1,078.89 | 557.73 | ||
| Total stockholders' equity | 119.24 | 160.88 | 195.31 | 122.56 | 209.08 | 250.50 | 292.48 | 339.65 | 375.14 | 287.51 | 365.85 | 355.03 | 428.26 | 499.32 | 566.02 | 639.51 | 701.66 | 728.50 | 830.09 | 905.90 | 881.98 | -421.18 | -311.18 | 274.82 | -142.54 | |
| Common shares outstanding | 277 | 253 | 260 | 238 | 238 | 236 | 235 | 234 | 217 | 197 | 200 | 193 | 191 | 190 | 189 | 188 | 186 | 184 | 182 | 191 | 183 | 175 | 130 | 130 | 130 | 159 |